journal article·2022-09

NIR‐II Photo‐Amplified Sonodynamic Therapy Using Sodium Molybdenum Bronze Nanoplatform against Subcutaneous Staphylococcus Aureus Infection

Xiaojun He, Ji‐Ting Hou, Xiaoshuai Sun, Paramesh Jangili, Jusung An, Yuna Qian, Jong Seung Kim, Jianliang Shen

Advanced Functional Materials· Volume 32· Issue 38
Publisher page

Abstract

Abstract Ultrasound (US)‐mediated sonodynamic therapy (SDT) has the advantages of non‐invasiveness and deep tissue penetration. Nanosystems are prominently used in sonosensitization; however, most nano‐sonosensitizers have a low reactive oxygen species (ROS) yield, thus restraining the application of SDT. Sodium molybdenum bronze nanoparticles (SMB NPs) with rich oxygen vacancies are developed and interlayer gaps of molybdenum trioxide nanobelts are expanded. Owing to the increased oxygen vacancy density and wide interlayer gap‐induced narrower band gap of SMB NPs, the electrons (e–) and holes (h+) generated by US are separated more rapidly, and oxygen vacancies prevent electrons–holes recombination under US irradiation. SMB NPs exhibit a second near‐infrared (NIR‐II) photothermal effect to promote the generation of ROS by the sonosensitizer. The SMB NPs system is successfully realized to eliminate Staphylococcus aureus (S. aureus) and dissipate biofilm. Therefore, multimodal therapy using SMB NPs serves as an effective and promising regimen for deep‐seated bacterial infections. The newly developed Mo‐based sonosensitizer is presented for the first time to demonstrate excellent antimicrobial activity through hyperthermia‐promoting SDT therapeutics. This work proposes a novel strategy in the field of NIR‐II photo‐amplified SDT with Mo‐based materials for bacterial eradication and other important biomedical applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Ultrasound and Hyperthermia Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Ophthalmology & Optometry School of Biomedical Engineering Wenzhou Medical University Wenzhou Zhejiang 325035 China

Department of Chemistry Korea University Seoul 02841 Korea

Wenzhou Institute University of Chinese Academy of Sciences Wenzhou Zhejiang 325000 China

Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health) Wenzhou Zhejiang 325001 China

Funding

National Natural Science Foundation of China · University of Chinese Academy of Sciences · Wenzhou Medical University · National Research Foundation of Korea · Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University · Science and Technology Plan Project of Wenzhou, China · Zhejiang Provincial Outstanding Youth Science Foundation

References (43)

Show source-provided references
1. 10.1038/nature1279010.1038/nature12790 ↗
2. 10.1038/nature1704210.1038/nature17042 ↗
3. 10.1039/C3CS60218D10.1039/C3CS60218D ↗
4. 10.1128/CMR.00084-1710.1128/CMR.00084-17 ↗
5. 10.1073/pnas.110029910810.1073/pnas.1100299108 ↗
6. 10.1002/anie.20190828910.1002/anie.201908289 ↗
7. 10.1038/nm114510.1038/nm1145 ↗
8. 10.1002/adma.20190410610.1002/adma.201904106 ↗
9. 10.1038/nmat454210.1038/nmat4542 ↗
10. Xue Z.‐H. · Joule · 2022
11. 10.1038/s41566-020-00703-910.1038/s41566-020-00703-9 ↗
12. 10.1039/C7CS00594F10.1039/C7CS00594F ↗
13. 10.1039/C9CS00648F10.1039/C9CS00648F ↗
14. 10.1021/acsnano.9b0866710.1021/acsnano.9b08667 ↗
15. 10.1002/adfm.20190795410.1002/adfm.201907954 ↗
16. 10.1002/anie.20211350610.1002/anie.202113506 ↗
17. 10.1021/jacs.9b1022810.1021/jacs.9b10228 ↗
18. 10.1016/j.bioactmat.2021.06.02110.1016/j.bioactmat.2021.06.021 ↗
19. 10.1002/adma.20180018010.1002/adma.201800180 ↗
20. 10.1021/acs.chemrev.7b0016110.1021/acs.chemrev.7b00161 ↗
21. 10.1002/adma.20190073010.1002/adma.201900730 ↗
22. 10.1002/anie.20200514310.1002/anie.202005143 ↗
23. 10.1002/adfm.20190859810.1002/adfm.201908598 ↗
24. 10.1021/acsnano.1c0342410.1021/acsnano.1c03424 ↗
25. 10.1038/nature0830210.1038/nature08302 ↗
26. 10.1002/smll.20200748610.1002/smll.202007486 ↗
27. 10.1039/D1NR00323B10.1039/D1NR00323B ↗
28. 10.1002/advs.20190015110.1002/advs.201900151 ↗
29. 10.1002/smll.20200573910.1002/smll.202005739 ↗
30. 10.1016/j.jconrel.2020.12.01510.1016/j.jconrel.2020.12.015 ↗
31. 10.1024/0300-9831/a00022610.1024/0300-9831/a000226 ↗
32. 10.1016/j.apcatb.2018.11.04710.1016/j.apcatb.2018.11.047 ↗
33. 10.1021/ja501866r10.1021/ja501866r ↗
34. 10.1038/s41467-020-15216-w10.1038/s41467-020-15216-w ↗
35. 10.1002/smll.20200417310.1002/smll.202004173 ↗
36. 10.1002/anie.20211593910.1002/anie.202115939 ↗
37. 10.1038/nature0907410.1038/nature09074 ↗
38. 10.1128/MMBR.00026-1910.1128/MMBR.00026-19 ↗
39. 10.1021/acs.nanolett.9b0429010.1021/acs.nanolett.9b04290 ↗
40. 10.1039/D0BM01084G10.1039/D0BM01084G ↗
41. 10.1016/j.tice.2021.10168310.1016/j.tice.2021.101683 ↗
42. 10.1021/jacs.1c0787510.1021/jacs.1c07875 ↗
43. 10.1002/advs.20210522310.1002/advs.202105223 ↗